You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-Complement System-AMY-101
AMY-101

Chemical Structure : AMY-101

CAS No.: 1427001-89-5

AMY-101 (Cp40, AMY101)

Catalog No.: PC-72455Not For Human Use, Lab Use Only.

AMY-101 (Cp40) is a peptidic inhibitor of the central complement component C3 for the management of patients with ARDS caused by SARS-CoV-2 infection.

Packing Price Stock Quantity
2 mg $398 In stock
5 mg $598 In stock
10 mg $958 In stock
25 mg Get quote
50 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

AMY-101 (Cp40) is a peptidic inhibitor of the central complement component C3 for the management of patients with ARDS caused by SARS-CoV-2 infection.
AMY-101 is a novel complement C3-targeted therapeutic based on the 3 rd-generation compstatin analog Cp40.

Physicochemical Properties

M.Wt 1789.11
Formula C83H117N23O18S2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

YICV-{Trp(Me)}-QDW-{Sar}-AHRC-{N(Me)Ile}-NH2 (Disulfide bridge:Cys3-Cys13)

References

1. Bostanci N, et al. J Proteome Res. 2018 Sep 7;17(9):3153-3175.

2. Reis ES, et al. Clin Immunol. 2018 Dec;197:96-106.

3. Mastellos DC, et al. Clin Immunol. 2020 Nov;220:108598.

4. Hasturk H, et al. J Clin Invest. 2021 Dec 1;131(23):e152973.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: